Global Gene Therapy in Oncology Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: Qy Research

Pages: 100

Report ID: 11134

Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient. 
In 2018, the global Gene Therapy in Oncology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gene Therapy in Oncology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy in Oncology development in United States, Europe and China.

The key players covered in this study
Bristol-Myers Squibb
Cold Genesys
Advantagene
Amgen
AstraZeneca
Bio-Path Holdings
CRISPR Therapeutics
Editas Medicine
Geron Corp
Idera Pharmaceuticals
Intellia Therapeutics
Johnson & Johnson
Marsala Biotech
Merck
Mologen AG
Oncolytics Biotech
Oncosec
Oncotelic
Shenzhen SiBiono GeneTech
Sillajen Biotherapeutics
Tocagen
UniQure
Ziopharm Oncology

Market segment by Type, the product can be split into
Ex Vivo
In Vivo

Market segment by Application, split into
Hospitals
Diagnostics Centers
Research Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gene Therapy in Oncology status, future forecast, growth opportunity, key market and key players.
To present the Gene Therapy in Oncology development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gene Therapy in Oncology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy in Oncology Market Size Growth Rate by Type (2014-2025)
1.4.2 Ex Vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy in Oncology Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Diagnostics Centers
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gene Therapy in Oncology Market Size
2.2 Gene Therapy in Oncology Growth Trends by Regions
2.2.1 Gene Therapy in Oncology Market Size by Regions (2014-2025)
2.2.2 Gene Therapy in Oncology Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gene Therapy in Oncology Market Size by Manufacturers
3.1.1 Global Gene Therapy in Oncology Revenue by Manufacturers (2014-2019)
3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gene Therapy in Oncology Market Concentration Ratio (CR5 and HHI)
3.2 Gene Therapy in Oncology Key Players Head office and Area Served
3.3 Key Players Gene Therapy in Oncology Product/Solution/Service
3.4 Date of Enter into Gene Therapy in Oncology Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gene Therapy in Oncology Market Size by Type (2014-2019)
4.2 Global Gene Therapy in Oncology Market Size by Application (2014-2019)

5 United States
5.1 United States Gene Therapy in Oncology Market Size (2014-2019)
5.2 Gene Therapy in Oncology Key Players in United States
5.3 United States Gene Therapy in Oncology Market Size by Type
5.4 United States Gene Therapy in Oncology Market Size by Application

6 Europe
6.1 Europe Gene Therapy in Oncology Market Size (2014-2019)
6.2 Gene Therapy in Oncology Key Players in Europe
6.3 Europe Gene Therapy in Oncology Market Size by Type
6.4 Europe Gene Therapy in Oncology Market Size by Application

7 China
7.1 China Gene Therapy in Oncology Market Size (2014-2019)
7.2 Gene Therapy in Oncology Key Players in China
7.3 China Gene Therapy in Oncology Market Size by Type
7.4 China Gene Therapy in Oncology Market Size by Application

8 Japan
8.1 Japan Gene Therapy in Oncology Market Size (2014-2019)
8.2 Gene Therapy in Oncology Key Players in Japan
8.3 Japan Gene Therapy in Oncology Market Size by Type
8.4 Japan Gene Therapy in Oncology Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gene Therapy in Oncology Market Size (2014-2019)
9.2 Gene Therapy in Oncology Key Players in Southeast Asia
9.3 Southeast Asia Gene Therapy in Oncology Market Size by Type
9.4 Southeast Asia Gene Therapy in Oncology Market Size by Application

10 India
10.1 India Gene Therapy in Oncology Market Size (2014-2019)
10.2 Gene Therapy in Oncology Key Players in India
10.3 India Gene Therapy in Oncology Market Size by Type
10.4 India Gene Therapy in Oncology Market Size by Application

11 Central & South America
11.1 Central & South America Gene Therapy in Oncology Market Size (2014-2019)
11.2 Gene Therapy in Oncology Key Players in Central & South America
11.3 Central & South America Gene Therapy in Oncology Market Size by Type
11.4 Central & South America Gene Therapy in Oncology Market Size by Application

12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gene Therapy in Oncology Introduction
12.1.4 Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2014-2019)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Cold Genesys
12.2.1 Cold Genesys Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gene Therapy in Oncology Introduction
12.2.4 Cold Genesys Revenue in Gene Therapy in Oncology Business (2014-2019)
12.2.5 Cold Genesys Recent Development
12.3 Advantagene
12.3.1 Advantagene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gene Therapy in Oncology Introduction
12.3.4 Advantagene Revenue in Gene Therapy in Oncology Business (2014-2019)
12.3.5 Advantagene Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gene Therapy in Oncology Introduction
12.4.4 Amgen Revenue in Gene Therapy in Oncology Business (2014-2019)
12.4.5 Amgen Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gene Therapy in Oncology Introduction
12.5.4 AstraZeneca Revenue in Gene Therapy in Oncology Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Bio-Path Holdings
12.6.1 Bio-Path Holdings Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gene Therapy in Oncology Introduction
12.6.4 Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2014-2019)
12.6.5 Bio-Path Holdings Recent Development
12.7 CRISPR Therapeutics
12.7.1 CRISPR Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gene Therapy in Oncology Introduction
12.7.4 CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2014-2019)
12.7.5 CRISPR Therapeutics Recent Development
12.8 Editas Medicine
12.8.1 Editas Medicine Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gene Therapy in Oncology Introduction
12.8.4 Editas Medicine Revenue in Gene Therapy in Oncology Business (2014-2019)
12.8.5 Editas Medicine Recent Development
12.9 Geron Corp
12.9.1 Geron Corp Company Details
12.9.2 Company Description and Business Overview
12.9.3 Gene Therapy in Oncology Introduction
12.9.4 Geron Corp Revenue in Gene Therapy in Oncology Business (2014-2019)
12.9.5 Geron Corp Recent Development
12.10 Idera Pharmaceuticals
12.10.1 Idera Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Gene Therapy in Oncology Introduction
12.10.4 Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2014-2019)
12.10.5 Idera Pharmaceuticals Recent Development
12.11 Intellia Therapeutics
12.12 Johnson & Johnson
12.13 Marsala Biotech
12.14 Merck
12.15 Mologen AG
12.16 Oncolytics Biotech
12.17 Oncosec
12.18 Oncotelic
12.19 Shenzhen SiBiono GeneTech
12.20 Sillajen Biotherapeutics
12.21 Tocagen
12.22 UniQure
12.23 Ziopharm Oncology

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details